On and effective December 21, 2023, Erin Henderson resigned as Chief Business Officer of Onconetix, Inc. (the ?Company?) to pursue other opportunities. The Company and Ms. Henderson are in the process of finalizing the terms of a Separation Agreement and a Consulting Agreement, pursuant to which Ms. Henderson will serve as a consultant to the Company for three months.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1116 USD | +0.36% | +0.36% | -43.64% |
05-20 | Onconetix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-43.64% | 2.98M | |
-2.99% | 89.49B | |
+2.24% | 40.67B | |
-12.86% | 33.15B | |
+61.72% | 26.45B | |
-20.07% | 14.69B | |
-7.68% | 12.89B | |
-12.64% | 11.54B | |
-42.60% | 11.34B | |
+4.27% | 8.84B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Onconetix, Inc. Announces Resignation of Erin Henderson as Chief Business Officer